Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
about
Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current ManagementClinical Practices and Outcomes on Chemotherapy-Induced Nausea and Vomiting Management in South Korea: Comparison with Asia-Pacific Data of the Pan Australasian Chemotherapy Induced Emesis Burden of Illness Study.The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomitingRelationship between traditional Chinese medicine constitutional types with chemotherapy-induced nausea and vomiting in patients with breast cancer: an observational study.Personalized Estimate of Chemotherapy-Induced Nausea and Vomiting: Development and External Validation of a Nomogram in Cancer Patients Receiving Highly/Moderately Emetogenic Chemotherapy.Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studiesIntegrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy.Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy.Resilience and Coping Strategies Influencing the Quality of Life in Patients With Brain Tumor.2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting.Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.New treatments on the horizon for chemoradiotherapy-induced nausea and vomiting.Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.Supportive Care in Older Adults with Cancer: Across the Continuum.Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients.2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy.Developing and implementing a complex Complementary and Alternative (CAM) nursing intervention for breast and gynecologic cancer patients undergoing chemotherapy--report from the CONGO (complementary nursing in gynecologic oncology) study.How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy.Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC).Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey.Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.Beyond current aprepitant evidence: room for improvement on dose selection and chemotherapy-induced nausea and vomiting risk factors.A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting.A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting.Acute chemotherapy-induced nausea and vomiting in children with cancer: Still waiting for a common consensus on treatment.Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study
P2860
Q30235971-C007BA6C-E5F3-4B16-BFEE-F773AA3601F6Q31045439-928C1CF9-DDAB-4C27-AD1A-3E65E6835660Q33749052-6A4139AC-7762-4371-A6AB-0E77EC238237Q36187964-D73297D4-82A3-4A55-AB6B-43505DE182E5Q36478194-8B2B2001-2A04-4BE2-A4A5-373ABBDEE3F3Q36510919-862D22AD-D107-417C-ADBF-2FD56E8CC0B4Q37347921-C325DD43-1928-469C-89E1-FC2265CBA088Q37480802-1015E13E-9DEC-4DEB-A7F8-31125AB7B1A6Q38665523-C4E3559E-B0AA-42AE-AD68-13EB8C8F4374Q38821611-958B2EBF-8E76-454A-BB92-34BB15BE8B6BQ38834889-B04FEDEC-1F9C-4D72-BAA8-CAFD6509C165Q38850896-FEAA4A0B-780B-405F-960B-400DAD985745Q38864988-52193775-7497-47F0-8B4D-08E609437958Q38876363-015E6764-0FE3-4E37-A901-D3329719E294Q38894275-AE0CDAC0-76E5-4977-806B-616DADB683A5Q38923999-D891B862-1823-40C5-B4A9-85013271E077Q39179881-BD384F9C-F5D7-40AB-A62E-066FB42B37D6Q46106401-CCEE921F-247F-4828-ACD4-74476AA09D06Q46355232-E6560F36-9B72-4C46-9026-5F3FF45F607EQ46448765-93BE2708-38E5-4237-8A84-DECD60928FA1Q46872839-0C1D3E4C-692E-49FA-9FB6-C9FE13E337DBQ47572333-B041023F-880E-4223-9DC0-66B29A034B3DQ47572599-59AE5D43-5775-49C5-8FD1-2D2004E1C891Q48090428-5589EDA7-7B67-42E8-8278-F11A186A3DF6Q48302132-B73E9F9D-1023-4E98-BA72-62B4808CFD5FQ48363175-A3DF82F3-C73B-45D1-8AC3-7274E68064CAQ49570044-09470D06-FA3C-42CF-A46A-B85BB2AE3079Q55101965-65E6F4D2-3B31-4E9E-A9D5-6D4EFD883424Q55514384-68FDB982-D65B-4AF6-814E-2E80453CD905Q57483443-5610E838-A75F-45EC-8EBA-6E00707CBD96
P2860
Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Evaluation of risk factors pre ...... ospective observational study.
@en
Evaluation of risk factors pre ...... ospective observational study.
@nl
type
label
Evaluation of risk factors pre ...... ospective observational study.
@en
Evaluation of risk factors pre ...... ospective observational study.
@nl
prefLabel
Evaluation of risk factors pre ...... ospective observational study.
@en
Evaluation of risk factors pre ...... ospective observational study.
@nl
P2093
P1476
Evaluation of risk factors pre ...... ospective observational study.
@en
P2093
Fausto Roila
Mario Dicato
Matti Aapro
Nicolas Isambert
Pere Gascon
Sylvia A Novoa
Thomas A Burke
P304
839-848.e4
P356
10.1016/J.JPAINSYMMAN.2013.06.012
P577
2013-09-24T00:00:00Z